Stereodynamic investigation of labile stereogenic centres in dihydroartemisinin
- PMID: 20335983
- PMCID: PMC6257325
- DOI: 10.3390/molecules15031309
Stereodynamic investigation of labile stereogenic centres in dihydroartemisinin
Abstract
Since its identification in the early 1970s, artemisinin, as well as semi-synthetic derivatives and synthetic trioxanes, have been used in malaria therapy. Reduction of artemisinin by NaBH4 produced dihydroartemisinin (DHA), and yielded a new stereochemically labile centre at C-10, which, in turn, provided two interconverting lactol hemiacetal epimers (namely alpha and beta), whose rate of interconversion depends on buffer, pH, and solvent polarity. Since interconversion of the two epimers occurred on a chromatographic time-scale, this prompted a thorough investigation of the phenomenon as a crucial requisite of any analytical method aimed at quantitating this family of drugs. In this critical review we discuss the current importance of the on-column epimerization of DHA in the development of analytical methods aimed at quantifying the drug, with the purpose of identifying the optimal conditions to minimize on-column epimerization while achieving the best selectivity and efficiency of the overall separation.
Figures









Similar articles
-
Stereolability of dihydroartemisinin, an antimalarial drug: a comprehensive thermodynamic investigation. Part 1.J Org Chem. 2011 Mar 18;76(6):1751-8. doi: 10.1021/jo102391s. Epub 2011 Feb 22. J Org Chem. 2011. PMID: 21341725
-
Stereolability of dihydroartemisinin, an antimalarial drug: a comprehensive kinetic investigation. Part 2.J Org Chem. 2011 Jun 17;76(12):4831-40. doi: 10.1021/jo102392p. Epub 2011 May 16. J Org Chem. 2011. PMID: 21542625
-
On-column epimerization of dihydroartemisinin: an effective analytical approach to overcome the shortcomings of the International Pharmacopoeia monograph.J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Nov 1;875(1):180-91. doi: 10.1016/j.jchromb.2008.06.037. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18617445
-
The Case for Development of 11-Aza-artemisinins for Malaria.Curr Med Chem. 2015;22(31):3607-30. doi: 10.2174/0929867322666150729115752. Curr Med Chem. 2015. PMID: 26219389 Review.
-
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708. Infect Disord Drug Targets. 2013. PMID: 24304352 Review.
Cited by
-
LC-UV/MS quality analytics of paediatric artemether formulations.J Pharm Anal. 2014 Feb;4(1):37-52. doi: 10.1016/j.jpha.2013.03.006. Epub 2013 Apr 25. J Pharm Anal. 2014. PMID: 29403867 Free PMC article.
-
Quantum Chemical Lipophilicities of Antimalarial Drugs in Relation to Terminal Half-Life.ACS Omega. 2020 Mar 23;5(12):6500-6515. doi: 10.1021/acsomega.9b04140. eCollection 2020 Mar 31. ACS Omega. 2020. PMID: 32258886 Free PMC article.
-
Chemometrics-assisted spectroscopic methods for rapid analysis of combined anti-malarial tablets.J Food Drug Anal. 2023 Jun 15;31(2):338-357. doi: 10.38212/2224-6614.3449. J Food Drug Anal. 2023. PMID: 37335160 Free PMC article.
References
-
- Guidelines for the Treatment of Malaria. World Health Organization; Geneva, Switzerland: 2006.
-
- Klayman D.L. Qinghaosu (artemisinin): An Anti-malarial Drug from China. Science. 1985;228:1049–1055. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources